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Pin1 is a phosphorylation-dependent peptidyl-prolyl isomerase (PPIase) that has the
potential to add an additional level of regulation within protein kinase mediated signaling
pathways. Furthermore, there is a mounting body of evidence implicating Pin1 in the
emergence of pathological phenotypes in neurodegeneration and cancer through the
isomerization of a wide variety of substrates at peptidyl-prolyl bonds where the residue
preceding proline is a phosphorylated serine or threonine residue (i.e., pS/T-P motifs).
A key step in this regulatory process is the interaction of Pin-1 with its substrates. This is
a complex process since Pin1 is composed of two domains, the catalytic PPIase domain,
and a type IV WW domain, both of which recognize pS/T-P motifs. The observation that
the WW domain exhibits considerably higher binding affinity for pS/T-P motifs has led to
predictions that the two domains may have distinct roles in mediating the actions of Pin1
on its substrates. To evaluate the participation of its individual domains in target binding,
we performed GST pulldowns to monitor interactions between various forms of Pin1 and
mitotic phospho-proteins that revealed two classes of Pin-1 interacting proteins, differing
in their requirement for residues within the PPIase domain. From these observations, we
consider models for Pin1-substrate interactions and the potential functions of the different
classes of Pin1 interacting proteins. We also compare sequences that are recognized by
Pin1 within its individual interaction partners to investigate the underlying basis for its
different types of interactions.
Keywords: peptidyl-prolyl isomerase, Pin1, phosphorylation-dependent interactions, WW domain, peptidyl-prolyl
isomerization
INTRODUCTION
Pin1 is unique amongst all the peptidyl-prolyl isomerases
(PPIases) because it interacts with phosphorylated serine or thre-
onine residues followed by a proline (pS/T-P) (Lu et al., 1996;
Ranganathan et al., 1997; Yaffe et al., 1997; Lu and Zhou, 2007).
Due to this phospho-specificity, Pin1 has been proposed to be a
regulatory timer of various cell signaling processes and is involved
in many important cellular functions including growth and pro-
liferation, immune responses, transcription, and apoptosis (Lu
et al., 2007; Yeh and Means, 2007; Esnault et al., 2008; Takahashi
et al., 2008). Pin1 is also implicated in diseases such as cancer
and Alzheimer’s disease and is a potential therapeutic target (Lu
et al., 2006; Yeh and Means, 2007; Takahashi et al., 2008). In spite
of the many functional studies and its therapeutic potential, the
molecular mechanisms and physiological roles of Pin1 binding
and catalysis are not fully elucidated (Lippens et al., 2007).
Pin1 is a 163 residue, two-domain protein with an N-terminal
WW domain and C-terminal catalytic or PPIase domain
(Ranganathan et al., 1997; Bayer et al., 2003). Both domains rec-
ognize pS/T-P motifs (Shen et al., 1998; Lu et al., 1999b). As the
WW domain has been reported to have a ten-fold higher binding
affinity for peptides than the PPIase domain in vitro, it is thought
to act as a protein interaction domain, functioning in protein
targeting and enhancing substrate specificity (Lu et al., 1999b;
Smet et al., 2005). Nevertheless, the catalytic PPIase domain also
exhibits phosphate-directed binding and has structural elements
critical for this function (Yaffe et al., 1997). Clearly identified in
the original structure (Ranganathan et al., 1997), and confirmed
by mutagenesis studies performed previously by Behrsin et al.
(2007), the residues K63, R68, and R69 form a positively charged
phosphate-binding loop to coordinate the phosphorylated ser-
ine or threonine. Further investigations aimed at elucidating a
role for phospho-protein binding by the PPIase domain have
been hampered by the low affinity binding of the PPIase domain
and the difficulty in generating full-length phosphorylated sub-
strates for in vitro studies. On this basis, it is not known how
the two domains of Pin1 coordinate their activities on full-length
substrates; it is also unclear whether all target phospho-proteins
interact with the two domains of Pin1 in the same manner.
At least three models have been proposed to explain how
both domains of Pin1 coordinate binding and isomerization of
its substrates: the sequential, multimeric, and catalysis-first mod-
els (Figure 1). The sequential model (Figure 1A) is based on the
apparent difference in affinity of the two domains for the tar-
get sequence. It proposes that the WW domain must either bind
first, then release, allowing the PPIase domain to catalyze the iso-
merization of the binding site; or remain bound, allowing the
PPIase domain to act on one or more other sites in the same
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FIGURE 1 | (A) The sequential binding model proposes that the WW domain
binds first, bringing the PPIase domain proximal to its targets (Zhou et al.,
1999; Lu et al., 2002). (B) The multimeric binding model proposes that the
WW domain anchors Pin1 in multimeric complexes, allowing the PPIase
domain to target other substrates in the complex (Jacobs et al., 2003).
(C) The catalysis-first binding model proposes that the PPIase domain
catalyzes the cis to trans isomerization of the target site to allow
trans-isomer-specific WW domain binding (Wintjens et al., 2001). (D) The
simultaneous binding model proposes that the WW and PPIase domains bind
simultaneously with low-affinity to multiply phosphorylated targets.
molecule (Zhou et al., 1999; Lu et al., 2002). This WW-domain-
directed sequential model is consistent with the large number of
multiply phosphorylated Pin1 substrates. The multimeric model
(Figure 1B) proposes that the WW domain anchors Pin1 in mul-
timeric complexes that include the upstream kinase creating the
Pin1 binding site (Jacobs et al., 2003). Thus, the substrate is
phosphorylated and isomerized by two members of the same
complex, with the PPIase domain already in high local concen-
tration when its binding site is created. The catalysis-first model
(Figure 1C) proposes that the PPIase domain is required to create
WW domain binding sites (Wintjens et al., 2001). In all available
structures of the WW-domain bound to substrate peptides, the
binding site is in the trans conformation (Verdecia et al., 2000;
Wintjens et al., 2001; Zhang et al., 2007). If the WW domain
exhibited isomer-specific binding, this would give Pin1-catalyzed
isomerization a cis to trans direction. The PPIase domain would
isomerize the substrate and form a WW-domain binding site.
This would allow the WW-domain to sequester the pool of trans-
substrate so that the PPIase domain could not catalyze the reverse
isomerization.
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To elucidate the substrate-binding role of the PPIase domain,
wild-type and active site mutants of Pin1 were used to pull
down phospho-proteins from mitotically arrested HeLa cell
extracts. From these studies we identified a class of Pin1 sub-
strates that require an intact PPIase domain phosphate-binding
loop for high affinity binding to full-length Pin1. To explain
the binding data, we propose a simultaneous model of bind-
ing (Figure 1D), in which certain Pin1 targets containing two
or more pS/T-P motifs bind with relatively low affinity to the
isolated WW and PPIase domains, but are able to interact simul-
taneously with both domains to bind full-length Pin1 with high
affinity.
METHODS
PLASMID CONSTRUCTION
Constructs for expression of GST, wild-type GST-Pin, and
GST-Pin1-C113S have been described previously (Bailey et al.,
2008). Human GFP-C1-Cdc25C was a gift from H. Piwnica-
Worms and was used as the template for subsequent Cdc25C
cloning. IndividualWW and PPIase domains of Pin1 were cloned
into PCR blunt (Invitrogen) and subcloned using NcoI and
HindIII into a pGEX vector. The GST-Pin1-R68A/R69A mutant
was generated using the Quikchange II Site-directed mutagen-
esis kit (Stratagene), according to manufacturer’s instructions.
pSPORT6-NonO containing human NonO cDNA was purchased
from ATCC.
GST FUSION PROTEIN PURIFICATION
GST protein expression and purification was performed as
described previously, with bacteria being grown in LB at 37◦C and
with overnight induction of protein with 0.6mM isopropylthio-
α-D-β-galactoside at 18◦C (Bailey et al., 2008). After purification
on glutathione-agarose (Sigma) and elution with 10mM reduced
glutathione (Sigma), proteins were dialyzed into PBS with 20%
glycerol at 4◦C. The protein concentration after dialysis was deter-
mined using the Bradford Protein Assay (Bio-Rad) and proteins
were stored at −80◦C until use.
CELL CULTURE AND TRANSFECTION
HeLa cells were maintained at 37◦C and 5% CO2 in DMEM
(Invitrogen) supplemented with 10% FBS and 1% peni-
cillin/streptomycin (Invitrogen). Transfection of cells at ∼80%
confluence was performed using the calcium phosphate method
with 80μg of total DNA/15 cm plate (Olsten et al., 2004).
Transfection efficiency was estimated at 50–70% under these con-
ditions. After 16–18 h, cells were washed with phosphate buffered
saline (PBS; Invitrogen) and fresh media was added. To arrest
cells in mitosis, cells were treated with 0.25μg/mL nocodazole
(Sigma) for 18 h before harvest. Cells were harvested by collecting
cells loosely attached to the tissue culture plate and resuspending
them in lysis buffer (50mM Tris-HCl, pH 8, 200mM NaCl, 10%
glycerol, 1% Triton X-100) with added protease and phosphatase
inhibitors: 1mM PMSF, 10μg/mL pepstatin A 1mg/mL leu-
peptin, 1μM microcystin-LR, 1mM DTT, 1mM sodium ortho-
vanadate, and 1μM okadaic acid. Cells were allowed to lyse on
ice on the bench top for 2–3 h and cell debris was then spun
down by centrifugation first at 13,000 rpm for 15min and then
at 55,000 rpm for 30min. Cell lysates were used immediately in
pull-downs.
GST PULL-DOWNS
For GST pull-downs, 200μg of GST fusion protein was bound
to glutathione cross-linked to agarose beads (Sigma). Beads were
washed twice with PBS buffer and once with lysis buffer then
incubated with 0.5–2mg of HeLa lysate for 1 h at 4◦C. Bound
proteins were washed with lysis buffer containing the following
protease and phosphatase inhibitors: 1mMPMSF, 10μg/mL pep-
statin A, 1mg/mL leupeptin, 1μM microcystin-LR plus 1mM
DTT. After washing 3–5 times, proteins were eluted into SDS
sample buffer by boiling. One two-hundredth of the eluted pro-
teins (by volume) of each pull-down was separated, diluted in
20μL of SDS sample buffer and separated by SDS-PAGE before
staining with Coomassie Blue to visualize GST fusion protein
loading.
Prominent bands on the stained gel were excised with an
Ettan Spot Picker (Amersham) and digested using trypsin at the
Functional Proteomics Facility (University of Western Ontario).
Samples were run on a MALDI-TOF and identified using the
MASCOT program.
WESTERN BLOTTING
Pull-downs were separated by SDS-PAGE and transferred to
polyvinyl difluoride membrane (Millipore). Primary antibodies
used include MPM-2 (2μg/mL; Millipore), Plk1 (1/500; Santa
Cruz), Cdc25C (C-20) (1/100; Santa Cruz), SFPQ (1μg/mL;
Abcam), NonO/p54nrb (1μg/mL; Abcam), HA (12CA5) (1/500;
Roche), and gamma tubulin. After incubation with primary anti-
bodies at 4◦C overnight, blots were washed and incubated with
either GAMorGAR secondary antibodies from Licor Biosciences.
Membranes were viewed on a LiCor imager and quantitation
was done using Odyssey software (Version 3.0). For quantita-
tion, band intensity on the blot was normalized for the amount
of GST fusion protein using the 1/200 Coomassie-stained gel and
corrected for the background in the GST lane.
BINDING-SITE SEQUENCE ANALYSIS
A comprehensive dataset of Pin1 interactors with defined binding
sites was produced from the literature. Only Pin1 targets that had
definitive binding sites for Pin1, where mutation or abrogation
of the site led to a loss of physical interaction as determined by
pull-downs or immunoprecipitations, were used in further anal-
ysis. Sequences and general protein data (specifically subcellular
location and available structural data) were obtained from the
UniProt Knowledgebase (Magrane and the UniProt consortium,
2011). Other data used to characterize the proteins identified
(protein function, and roles in cancer and neurodegeneration)
were gathered from literature sources, with citations available in
Data Sheet 1. Prediction of regions of disorder and secondary
structure features were performed using the DISOPRED2 and
PSIPRED (Jones, 1999; Ward et al., 2004). Protein kinases act-
ing on the identified sites were predicted using the Group-based
Phosphorylation Scoring Method (GPS) tool, but a lack of con-
fidence in the output led to manual annotation of the kinases
involved from literature sources, when available (Zhou et al.,
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2004; Xue et al., 2005). Electrostatic analysis of the Pin1 tar-
get sequences was performed using the ExPASy Server’s batch pI
computational tool, using the 10 residue peptide sequence cen-
tered on the S/T-P motif of each site as a representative model
(Gasteiger et al., 2005).
RESULTS AND DISCUSSION
BINDING BY THE PPIase DOMAIN PHOSPHATE-BINDING LOOP IS
REQUIRED FOR Pin1 INTERACTION WITH SELECT TARGETS
Two catalytically deficient mutants of Pin1 were previously gener-
ated, one in which the R68 and R69 residues of the PPIase domain
phosphate-binding loop were mutated to alanine (R68A/R69A),
and the other in which C113 of the active site was mutated
to serine (C113S) (Zhou et al., 2000; Behrsin et al., 2007). To
assess the role of the PPIase domain in target binding, we used
GST fusion proteins encoding wild-type Pin1 or the catalytically
deficient Pin1 mutants to pull down Pin1 interacting proteins
in nocodazole-arrested HeLa lysates. Figure 2A shows that wild-
type Pin1 (lane 2) and the C113S mutant (lane 4) are equally
capable of pulling down Pin1 target proteins. In contrast, the
R68A/R69A mutations (lane 3) resulted in an overall decrease
in binding. R68 and R69 are part of a large, somewhat flex-
ible loop that coordinates the phosphate when substrates are
bound to the PPIase domain (Ranganathan et al., 1997; Verdecia
et al., 2000). The fact that the R68A/R69A mutations negatively
affected target binding while the C113S mutation did not sug-
gests that the decreased binding seen with R68A/R69A is not
related to isomerase activity but is due to a binding defect in the
PPIase domain. This result was unexpected, since the reported
higher affinity of the WW domain for phosphorylated motifs was
thought to mediate Pin1 target binding.
To further dissect the role of the PPIase domain in tar-
get binding, GST pull-downs were carried out using the same
mitotic extracts, and mitotic phospho-proteins were specifically
identified with the MPM-2 antibody (Figure 2B, top panel), an
antibody generated against a mitotic lysate that recognizes com-
mon Pin1 target phosphoepitopes (Davis et al., 1983; Yaffe et al.,
1997; Shen et al., 1998). Again, wild-type Pin1 (GST-WT) and
the C113S mutant (GST-C113S) yielded similar profiles. The
R68A/R69A (GST-R68A/R69A) and the isolated WW domain
(GST-WW) were somewhat compromised in their ability to bind
mitotic phospho-proteins; the isolated PPIase domain (GST-
PPIase) failed to pull down any phospho-proteins. Thus, the
PPIase domain appears to play a role in target binding. This
appears to be primarily in conjunction with the WW domain,
but we cannot rule out WW domain independent targets. The
prediction that the WW domain and PPIase domain have dif-
ferent specificities is further reinforced by the identification of
PPIase domain-specific inhibitors that do not interact with the
WW domain (Duncan et al., 2011).
These PPIase domain-dependent interactions led us to
hypothesize that select multiply phosphorylated targets may bind
with high affinity to Pin1 by simultaneous low-affinity inter-
actions with both the WW domain and the PPIase domain.
The loss of binding due to the R68A/R69A mutations was
not globally affecting Pin1 targets, suggesting that binding of
one target population requires only the WW domain, while
binding of a second target population requires both the WW
domain and the PPIase domain with an intact phosphate binding
loop (PBL).
The hypothesis that particular targets require simultaneous
interaction with both the WW and the PPIase domain was tested
using the known Pin1 targets Plk1 and Cdc25C (Figure 2B,
2nd and 3rd panel, Figure 2C). Both proteins bound well to
full-length Pin1, and equally well to the catalytically deficient
C113S mutant. Following the trend of some of the proteins from
the MPM-2 blot above, Plk1 and Cdc25C bound poorly to the
R68A/R69A mutant of Pin1. Consistent again with the MPM-
2 blot, the PPIase domain was unable to bind these proteins,
whereas the isolated WW domain also bound poorly. This is
surprising given that the WW domain and the PPIase domain
exhibit respective KD values of 1.2μM and 11μM to the opti-
mal Pintide substrate (WFYpSPFLE; Lu et al., 1999b). The fact
that both the isolated WW domain and R68A/R69A mutant are
deficient in binding to Plk1 and Cdc25C—whereas the C113S
mutant shows no such deficit—indicate that the PPIase domain
plays a role in binding these proteins, and this role can be
traced to its phosphate-binding loop. This suggests that in cases
where the WW domain has weaker affinity for Pin1 targets, the
PPIase domain phosphate-binding loop can contribute, perhaps
by binding to a second Pin1 site.
Such a role for the PPIase domain in target binding is not
universal. In this respect, the two most prominent bands in our
pull-down, located at ∼50 kDa and ∼85 kDa bound similarly to
all GST fusions tested, including GST-R68A/R69A. These bands
were identified using MALDI-TOF MS as NonO/p54nrb and its
obligate binding partner SFPQ/PSF. The identities of these bands
were further confirmed by immunoblotting with antibodies spe-
cific to NonO and SFPQ. Both NonO and SFPQ showed robust
binding to all GST fusion proteins except the isolated PPIase
domain.
We wanted to ensure that the PPIase domain-independent
binding of NonO and SFPQ was not due to their abundance.
Therefore, pull-downs with Pin1 mutants were performed and
serial dilutions of the pull-down run on a Western Blot. Lower
serial dilutions did not show any difference between R68A/R69A
and wild-type with respect to their interactions with NonO
(Figure 3A). NonO levels were also the same when a lower
amount of lysate was used in the pull-downs (Figure 3B).We then
exogenously expressed NonO at lower levels than the endoge-
nous protein (Figure 3C) and compared levels of both HA-NonO
and HA-Cdc25C in Pin1 pull-downs on the same blot. We
found that, like their endogenous counterparts, NonO still bound
R68A/R69A while Cdc25C did not (Figure 3D). Collectively,
these results confirm that binding of NonO to Pin1-R68A/R69A
is not simply due to its abundance.
We have identified two groups of proteins—one that includes
NonO and SFPQ, and a second including Cdc25C and Plk1—that
demonstrate different sensitivity to the loss of the PPIase domain
phosphate-binding loop. The differences in binding suggests that
the PPIase domain and the WW domain bind simultaneously to
two pS/T-P sites in Cdc25C and Plk1, whereas the WW domain
is sufficient for binding to a single pS/T-P site in NonO and
SFPQ. Consequently, there may be at least two different classes of
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FIGURE 2 | GST pull-downswith Pin1mutants reveal two different types
of binding proteins. (A) Large-scale GST pull-downs. One to twomilligrams of
nocodazole-treated HeLa lysates were incubated with GST fusion proteins
bound to glutathione beads. Interacting proteins were run on a 5–12% gradient
gel and stained with Coomassie Blue. (B)GST pull-downs were performed as in
(A)with 1mg of HeLa lysate. Interacting proteins were run on 10% SDS-PAGE,
transferred to PVDF and blotted with the indicated antibody. To better compare
the amount of fusion protein on the beads, 1/200 of each pull-downwas run on a
gel and stained with Coomassie Blue (PD). (C)Quantification of blots shown in
(B). Results are themeanof three independent pull-downexperiments±S.E.M.
Pin1 interactors: one class that requires an intact PPIase domain
phosphate-binding loop for their association with Pin1 (which
we will refer to as PBL-dependent binding proteins) and another
where an intact PPIase domain is not critical for binding (named
PBL-independent binding proteins). To our knowledge, this is the
first study to suggest that the Pin1 isomerase domain plays a direct
and critical role in the association of Pin1 with a subset of its
interacting proteins.
SEQUENCE CHARACTERISTICS OF Pin1 BINDING SITES
In an effort to identify the determinants for PBL-dependent
and -independent binding, we examined the binding site
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FIGURE 3 | p54nrb/NonO binding to R68A/R69A is not due to protein
abundance. (A)One to two milligrams of nocodazole-treated HeLa lysates
were incubated with GST fusion proteins bound to glutathione beads. Serial
dilutionsof thepull-downwere run on a5–12%gradient gel, and immunoblotted
with anti-p54nrb/NonO. (B) Hundred micrograms of nocodazole-treated HeLa
lysates (N/C) were incubated with GST fusion proteins bound to glutathione
beads. Interacting proteins were run on a 5–12% gradient gel and stained with
Coomassie Blue. (C) HeLa cells were either transfected with HA-NonO or left
untransfected (NT). Lysates were used in GST pull-downs (PD’s) as above and
immunoblotted with the indicated antibody. Endogenous NonO is indicated
with End. (D) HeLa cells were transfected with HA-NonO or HA-Cdc25C or left
untransfected (NT). Lysates were used in pull-downs (PD) as above and
transfected proteins were detected with anti-HA. For the combined sample,
1mg of HA-NonO lysate was mixed with 1mg of HA-Cdc25C lysate.
sequences of known Pin1 interacting proteins. Only Pin1 targets
that have defined binding sites for Pin1, where mutation or abro-
gation of the site led to a loss of physical interaction as determined
by pull-downs or immunoprecipitations, were used in the analy-
sis. With these criteria, we found 71 proteins containing a total
of 120 Pin1 binding sites (Data Sheet 1). Cellular functions of
these 71 proteins varied with almost half involved in growth and
the cell cycle (Figure 4A). Furthermore, over half of the proteins
identified can be found in the nucleus (Figure 4B) consistent with
Pin1 localization (Lu et al., 1996). In the 120 sites analyzed, 98
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FIGURE 4 | (A) Functional categorization of Pin1 interactors. (B) Subcellular
location of Pin1 interactors, from UniProtKB. (C) Frequency chart of amino
acids in the alignment of Pin1 binding sites oriented at the S/T-P motif, using
the WebLogo service (Schneider and Stephens, 1990; Crooks et al., 2004).
were predicted to be in regions of disorder, and the remaining
22 sites were in surface loops rather than regions of constrained
secondary structure. This is consistent with Pin1 preferring to
act on flexible, unstructured regions of the protein, which allow
space for the 180◦ rotation needed for isomerization (Lippens
et al., 2007). As expected, given the exposed hydrophobic sur-
face of the Pin1 catalytic site, the binding sequences are relatively
hydrophobic.
Analysis of the Pin1 binding sites showed considerable vari-
ability at positions around the S/T-P motif (Figure 4C). Residues
surrounding the pS/T-P motif in Pin1 binding sites are most fre-
quently proline, serine, leucine, and alanine. This result contrasts
with the optimal high affinity Pin1 binding site, W/F/Y-F/I-
Y/R/F/W-pS-P-R/F/Y/W-L/I, that was identified through screen-
ing of a degenerate peptide library (Yaffe et al., 1997). The very
strong preference for aromatic residues is not readily apparent
in bona-fide Pin1 binding sites. This observation, along with
the degenerate nature of the Pin1 binding sequences identi-
fied in bona-fide targets, may be explained by the multitude of
signaling processes in which Pin1 is involved (see Figure 4A).
Since Pin1 binding is phosphate-directed, its binding sites must
also act as targets for kinases. With Pin1 involved in multiple
signaling pathways, its targets are phosphorylated by a vari-
ety of different kinases, each with different sequence specificity
(Data Sheet 1). Additionally, Pin1 may share its binding site with
the phosphatases that sometimes act on a protein following a
Pin1-catalyzed isomerization event. Thus, Pin1 must have flexi-
ble sequence requirements in order to coordinate its actions with
multiple signaling pathways.
BINDING SITES WITH A PROLINE AT THE +1 POSITION MAY
PREFERENTIALLY TARGET THE Pin1 WW-DOMAIN
The goal of creating a functional alignment of Pin1 target
sequences was to identify differential sequence determinants for
the two classes of Pin1 interacting proteins. While this revealed
the highly variant nature of the sequence surrounding the canon-
ical pS/T-P binding motif, the minimal information present in
the alignment made identifying patterns difficult (Figure 4C).
Consequently, we turned to a structural approach to differenti-
ate the two classes of Pin1 targets. Although the two domains
of Pin1 bind to the same pS/T-P sequence, structures of these
domains with peptides or peptide inhibitors show the bound pep-
tides adopt different conformations. Peptides bound to the WW
domain are extended, with little bend induced in the peptide
backbone (Figure 5A; Verdecia et al., 2000). The only structures
of the PPIase domain bound to a longer peptide are those with a
PPIase specific peptide inhibitor (Zhang et al., 2007). The back-
bone of the peptides in these structures forms a type I β-turn
in the active site of Pin1. This places the carbonyl oxygen of the
phosphorylated serine or threonine and the amino hydrogen of
the amino acid C-terminal to the proline (i.e., in the +1 posi-
tion) close enough together to form an intramolecular hydrogen
bond. However, if the +1 residue in the Pin1 site were proline,
then there would not be an amino hydrogen at the +1 position
to form this bond. This may alter the affinity of the peptide for
the PPIase domain by destabilizing the β-turn conformation that
seems to be required for binding. Therefore, pS/T-P sites with an
additional prolyl residue at the +1 position (i.e., pS/T-P-P) are
unlikely to bind to the PPIase domain.
A +1 proline could explain the difference between PBL-
dependent and -independent binding proteins. Interestingly, two
of the three Pin1 binding sites in the PBL-independent pro-
tein NonO have proline in the +1 position (Figure 5B). Unlike
PBL-dependent proteins, which bind both Pin1 domains simul-
taneously, the two pT-P-P sites in NonO would not bind to the
PPIase domain, distinguishing its binding as independent of the
PPIase domain. On the other hand, neither of the two sites of
Cdc25C contain a proline at the +1 position, suggesting that
either may associate with the PPIase domain during binding to
Pin1. Unfortunately it is difficult to test the model further, since
the binding sites of SFPQ and Plk1 have not been explicitly iden-
tified. SFPQ contains two potential Pin1 sites, at pS(33)-P and
pT(687)-P (Dephoure et al., 2008), the former of which contains
a proline in the +1 position, and therefore fits the model that sites
with a +1 proline are associated with PBL-independent binding
partners of Pin1. Plk1 also contains two potential Pin1 bind-
ing sites at pT(214)-P and pT(498)-P, neither of which contains
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FIGURE 5 | Phosphopeptide binding by the WW and PPIase domains.
(A) Structures of the WW domain (left, 1F8A) and PPIase domain (right, 2ITK)
of Pin1 bound to peptides or peptide inhibitors. A general trace of the
backbone of the peptide is shown in blue. (B) Sequences of sites in the two
Pin1 binding proteins used in this study, Cdc25C and NonO, with pT-P and +1
residues highlighted.
a +1 proline (Daub et al., 2008). The lack of a +1 proline at
either site matches what was seen with the other identified PBL-
dependent Pin1 interacting protein, Cdc25C. The presence of
a pS/T-P-P binding site may prevent simultaneous binding by
both the WW and PPIase domains because the PPIase domain
is unable to bind to these sites. In addition, this pS/T-P-P motif
may have sufficiently high affinity for the WW domain to allow
for the PBL-independent binding seen in the sequential binding
model.
There is additional evidence from the literature that pS/T-P-P
motifs bind preferentially to the WW domain, and that the pres-
ence of these sequences in a target makes its interaction with Pin1
PBL-independent. For example, NMR experiments have shown
that the WW domain of Pin1 binds to both pT(212)-P-S and
to pT(231)-P-P of Tau, but the PPIase domain only binds to
the pT(212)-P-S site, indicating that the +1 proline may con-
fer WW domain-specificity (Smet et al., 2004, 2005). The WW
domain-specific nature of the pT(231)-P-P site may also make
Tau a PBL-independent Pin1 interactor. This was shown using a
K63Amutant of Pin1, which abolishes PPIase domain phosphate-
binding by mutating the third critical basic residue of the PBL
(Lu et al., 1999a; Behrsin et al., 2007). Phosphorylation of the
T(231)-P-P site of Tau is sufficient for interaction with both wild-
type Pin1 and the K63A mutant (Lu et al., 1999a), suggesting
that Tau is a PBL-independent interactor. Similarly, interac-
tion between K63A Pin1 and peroxisome proliferator-receptor
γ (PPARγ) is mediated by pS(84)-P-P (Fujimoto et al., 2010),
indicating that PPARγ may also be a PBL-independent target of
Pin1. CREB-regulated transcriptional coactivator 2 (CRTC2, aka
TORC) also shows PPIase domain-independent binding to Pin1,
via the pS(136)-P-P site of its nuclear localization signal (Nakatsu
et al., 2010). Thus, we hypothesize that a proline in the +1 posi-
tion may define a WW domain-specific binding site and have
sufficient affinity for the WW domain to allow Pin1 to bind to
proteins with this motif independently of the phosphate-binding
loop of the PPIase domain.
There are a number of functional implications of this WW
domain-specific binding site. In terms of binding models, it
would fit both the sequential and multimeric models, as this site
would be the initial binding site for Pin1, bringing the PPIase
domain proximal to its target sites, whether on the same pro-
tein, or other proteins in the complex. However, it may also serve
a novel function, through its decreased affinity for the PPIase
domain. The behavior of this site in Tau, where the pT(231)-P-P
site cannot be isomerized by Pin1, may indicate that these sites
cannot be bound and isomerized by the PPIase domain, suggest-
ing that these sites are purely used for protein-protein interaction.
Given their high affinity for the Pin1WWdomain, they may serve
as reservoirs or sinks, binding Pin1 and sequestering it from its
substrates as a regulatory mechanism. It is interesting that almost
all Pin1 targets with only a WW domain-specific binding site are
found in the cytoplasm, whereas Pin1 and the majority of its
substrates are found in the nucleus (Table 1). The cytoplasmic
fraction of Pin1 may therefore be predominantly “inactivated”
through physical separation from its substrates, by WW domain-
mediated association with these proteins. This may have impli-
cations when designing therapeutic compounds to inhibit Pin1,
since blocking theWWdomain would therefore increase the frac-
tion of Pin1 available to its substrates. Further investigation into
the various binding models of Pin1 with multiply phosphorylated
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Table 1 | Pin1 substrates containing one or more binding sites with a proline in the +1 position.
Name Kinase Effect of Pin1 Subcellular location
FoxO4 Akt Inhibition Cytoplasm/Nucleus
Notch1 Erk1/2.JNK Increased transcriptional activity Cell membrane
PML unknown Destabilization Cytoplasm/Nucleus
SMAD 3 unknown Destabilization Cytoplasm/Nucleus
Myc GSK-3beta Dephosphorylation and destabilization Nucleus
NonO Cdk1 Unknown Nucleus
NHERF-1 Cdk1 Dephosphorylation and inhibition Cytoplasm
PKB PI3K Stabilization Cytoplasm/Nucleus
Tau unknown Dephosphorylation and neuroprotective Cytoskeleton
TFG unknown Activation Unknown
CRTC2 unknown Inhibition Cytoplasm/Nucleus
FADK1 Erk1/2 Dephosphorylation and inhibition Cytoplasm/Nucleus
Mcl-1 Erk1/2 Stabilization Cytoplasm/Nucleus
NF-kappa-B p65 unknown Stabilization Cytoplasm/Nucleus
Oct3/Oct4 unknown Stabilization and increased transcription Nucleus
PPAR-gamma MAPK.JNK Stabilization Cytoplasm/Nucleus
RARalpha Cdk7 Destabilization Cytoplasm/Nucleus
SF-1 Cdk7.Erk1/2 Increased transcriptional activity Nucleus
Tax-1 unknown Activation Cytoplasm/Nucleus
Highlighted entries contain only the +1 proline binding site.
targets, including WW domain-specific sites, will help clarify the
potential functional implications of each binding model.
CONCLUDING REMARKS
This study characterized the binding properties of the
R68A/R69A mutant of the Pin1 isomerase domain, and in doing
so, identified a class of Pin1 interactor that requires both the WW
domain and phosphate-binding loop of the PPIase domain for
protein–protein interaction. To account for the binding charac-
teristics of these targets, a new simultaneous model of binding
was proposed, in which the simultaneous binding of the two
domains of Pin1 at two independent sites on an interacting pro-
tein overcomes poor binding by each of the individual domains.
In an attempt to identify the sequence or structural determi-
nants separating these two classes of interactors, a comprehensive
analysis of Pin1 interacting proteins with known binding sites
was undertaken. Following a structural comparison of peptides
bound to the WW and PPIase domains of Pin1, we proposed that
a proline positioned C-terminal to the pS/T-P Pin1 binding site
decreases PPIase domain affinity, and the interactions between
Pin1 and these targets are therefore mediated exclusively through
the WW domain. The concept of a WW-domain-specific binding
site helps reinforce the sequential model of Pin1 binding, in which
the WW-domain binds one site of a multiply phosphorylated tar-
get protein, targeting the catalytic domain to the appropriate
site. Further studies comparing singly and multiply phospho-
rylated Pin1 targets must be undertaken to evaluate both the
simultaneous and sequential models of Pin1 interaction. While
the importance of Pin1 in oncogenesis is understood, attempts
to use it as a therapeutic target may be impeded by the various
ways in which Pin1 interacts with its targets. In this regard the
identification of two classes of Pin1 interactors is highly relevant
to pharmaceutical development, as it indicates the importance of
developing agents to each of the individual domains.
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